Mapping Mouse Prostate and Understanding Treatment Resistance
Author Information
Author(s): Cho Hanbyul, Zhang Yuping, Tien Jean C., Mannan Rahul, Luo Jie, Narayanan Sathiya Pandi, Mahapatra Somnath, Hu Jing, Shelley Greg, Cruz Gabriel, Shahine Miriam, Wang Lisha, Su Fengyun, Wang Rui, Cao Xuhong, Dhanasekaran Saravana Mohan, Keller Evan T., Pitchiaya Sethuramasundaram, Chinnaiyan Arul M.
Primary Institution: Cold Spring Harbor Laboratory
Hypothesis
What are the cellular mechanisms driving inadequate response to androgen deprivation therapy in prostate cancer?
Conclusion
The study reveals that specific cell types in the mouse prostate are linked to treatment resistance in prostate cancer.
Supporting Evidence
- Mouse prostates have unique cell types that respond differently to treatment.
- Castration changes the way prostate cells behave, leading to treatment resistance.
- Certain cell types are enriched in areas of the prostate that are more resistant to therapy.
Takeaway
Researchers created a detailed map of mouse prostate cells to understand why some prostate cancer treatments stop working. They found specific cells that might help explain this problem.
Methodology
The study used single-cell RNA sequencing, multiomics, and spatial transcriptomics to analyze mouse prostate cells.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website